Ablation of luteal phase symptoms of Menière's disease with leuprolide.

Published

Journal Article

Symptoms of Menière's disease in women may be exacerbated during the luteal phase of the menstrual cycle. This suggests a role for progesterone production and subsequent fluid redistribution as a predisposing factor for Menière's symptoms. We report the use of leuprolide acetate, a gonadotropin-releasing hormone agonist, in a woman with cyclic Menière's symptoms. This drug, which abolishes gonadotropin-dependent ovarian sex steroid production, alleviated the patient's symptoms during therapy. This observation offers further support to the hypothesis of sex hormone-related exacerbations of Menière's symptoms and provides a possible future treatment option for this debilitating disease.

Full Text

Duke Authors

Cited Authors

  • Price, TM; Allen, TC; Bowyer, DL; Watson, TA

Published Date

  • February 1994

Published In

Volume / Issue

  • 120 / 2

Start / End Page

  • 209 - 211

PubMed ID

  • 8297581

Pubmed Central ID

  • 8297581

Electronic International Standard Serial Number (EISSN)

  • 1538-361X

International Standard Serial Number (ISSN)

  • 0886-4470

Digital Object Identifier (DOI)

  • 10.1001/archotol.1994.01880260079015

Language

  • eng